<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Mechanism for laser-induced neovascularization in rat choroid: Accumulation of integrin α chain-positive cells and their ligands</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2014-06-19">19 June 2014</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Nakajima</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Senju Laboratory of Ocular Sciences</orgName>
								<orgName type="institution">Senju Pharmaceutical Co., Ltd</orgName>
								<address>
									<settlement>Kobe</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayuki</forename><surname>Hirata</surname></persName>
							<affiliation key="aff1">
								<orgName type="laboratory">Senju Laboratory of Ocular Sciences</orgName>
								<orgName type="institution">Senju Pharmaceutical Co., Ltd</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Integrative Biosciences</orgName>
								<orgName type="institution">Oregon Health &amp; Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">R</forename><surname>Shearer</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Integrative Biosciences</orgName>
								<orgName type="institution">Oregon Health &amp; Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mitsuyoshi</forename><surname>Azuma</surname></persName>
							<email>mitsuyoshi-azuma@senju.co.jp</email>
							<affiliation key="aff0">
								<orgName type="laboratory">Senju Laboratory of Ocular Sciences</orgName>
								<orgName type="institution">Senju Pharmaceutical Co., Ltd</orgName>
								<address>
									<settlement>Kobe</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">Senju Laboratory of Ocular Sciences</orgName>
								<orgName type="institution">Senju Pharmaceutical Co., Ltd</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Integrative Biosciences</orgName>
								<orgName type="institution">Oregon Health &amp; Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="laboratory">Senju Laboratory of Ocular Sciences OTRADI Bioscience Incubator</orgName>
								<address>
									<addrLine>4640 SW Macadam Ave., Suite 200C</addrLine>
									<postCode>97239</postCode>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Mechanism for laser-induced neovascularization in rat choroid: Accumulation of integrin α chain-positive cells and their ligands</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2014-06-19">19 June 2014</date>
						</imprint>
					</monogr>
					<note type="submission">Received 8 December 2013 | Accepted 17 July 2014 |</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:02+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>Choroidal neovascularization (CNV) is a major cause of severe central vision loss in patients with exudative, age-related macular degeneration (AMD) [1]. In patients with exudative AMD, choroidal blood vessels grow through Bruch&apos;s membrane into the subretinal space. This is followed by leakage and accumulation of serum or blood beneath the RPE, leading to retinal damage and rapid loss of vision [2]. Human ocular neovascularization may be caused or facilitated by altered expression of integrins [3,4]. Integrins are heterodimeric, cell surface receptors found in nearly all metazoan cell types. These receptors are composed of noncovalently linked α-and β-subunits [5,6]. In mammals, 18 α-subunits and eight β-subunits have been identified [7]. The subunit composition of the heterodimer determines binding to specific ligands in the extracellular matrix (ECM). For example, α5β1 and αvβ3 integrins bind to their ligands fibronectin (FN) and vitronectin (VN), respectively, which are strongly expressed around developing vasculature [5,8,9]. Therefore, α5β1 and αvβ3 integrins have been investigated the most as potential regulators of angiogenesis [10]. Integrin αvβ3 was the first integrin associated with angiogenesis [11], and deletion of the α5 gene is embryonically lethal with vascular and cardiac defects [12]. These integrin-mediated interactions are also required for pathological processes such as angiogenesis [13], tumor survival, and metastasis [14].</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Laser irradiation encircling the optic nerve is widely used for inducing CNV in rodent <ref type="bibr" target="#b15">[15]</ref> and primate <ref type="bibr" target="#b16">[16]</ref> models of AMD. During experimental choroidal neovascularization, the binding of inhibitors to integrins α5 and αv is antiangiogenic. For example, systemic administration of α5β1 integrin antagonist causes CNV suppression and regression <ref type="bibr" target="#b17">[17]</ref>. An αvβ3 specific antagonist also inhibits laser-induced CNV in mice <ref type="bibr" target="#b18">[18]</ref>. However, the expression of integrin α5 and αv subunits with time is limited in these models, and the localization of integrin ligands such as FN and VN has not been reported. Thus, the purposes of the present study in the laser-induced CNV model were as follows: 1) to identify integrin α chainpositive cells and their ligands FN and VN and 2) to measure the binding of integrins to their ligand ECMs. Laser-induced choroidal neovascularization model: Rats were anesthetized with a 1 ml/kg bodyweight intraperitoneal injection of a mixture containing ketamine hydrochloride (50 mg/ml; Daiichi Sankyo, Tokyo, Japan) and xylazine hydrochloride (10 mg/ml; Bayer, Tokyo, Japan). Pupils were dilated with topical tropicamide/phenylephrine (Midrin-P, Santen Pharmaceutical, Osaka, Japan). Visualization of the fundus was aided by placing a cover glass on the eye over hydroxyethylcellulose. A slit-lamp biomicroscope (NIDEK, Aichi, Japan) was used to encircle the optic nerve on the retina with six to seven laser spots (100 µm each, 532 nm, 150 mW, 0.1 s). Breakage of Bruch's membrane was confirmed by bubble formation and used as an end point for treatment. Animals with severe hemorrhages in the retina were excluded from the study. Two rat eyes in the experimental group were choroidal flatmounted and subjected to immunohistochemistry as described below.</p><p>Choroidal flatmounts: After euthanasia on day 1, 3, 7, or 14 following laser photocoagulation, the eyes were enucleated and prefixed with 4% paraformaldehyde (Nacalai tesque, Kyoto, Japan) for 30 min. Retina-RPE-choroid complexes were microsurgically isolated from the prefixed eyes and further fixed with 4% paraformaldehyde for 1 h. The retina was removed from RPE-choroid complexes. The RPE-choroid complexes were then washed with PBS (1X; 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 :Nacalai tesque) and incubated for 30 min with PBS blocking buffer containing 0.5% Triton X-100 (GE Healthcare UK, Buckinghamshire, UK) and 1% bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, MO). To visualize neovascularization, RPE-choroid complexes were incubated overnight at 4 °C with 0.01% fluorescein isothiocyanate (FITC)-conjugated isolectin B4 derived from Griffonia (Bandeiraea) simplicifolia agglutinin (Vector Laboratories, Peterborough, UK) diluted with PBS containing 0.5% Triton X-100. After the RPE-choroid complexes were washed with PBS and sealed with VECTASHIELD (Vector Laboratories), CNV was observed with a fluorescence microscope (IX71; Olympus, Tokyo, Japan). Note that FITC-labeled isolectin binds to microglial cells and macrophages as well as endothelial vascular cells <ref type="bibr" target="#b19">[19]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry for integrins and extracellular matrix:</head><p>Enucleated eyes in embedding medium (Tissue-Tek OCT Compound; Sakura Finetek, Torrance, CA) were flash-frozen with liquid nitrogen. Serial sections (10 μm) were cut on a cryostat at −20 °C and collected with adhesive film (Cryofilm type 2C(9); SECTION-LAB, Hiroshima, Japan). The sections were fixed with 75% ethanol at −20 °C for 30 min, washed three times with Tris-Buffer Saline (TBS; 2 mM Tris, 50 mM NaCl, pH7.4; BioRad Laboratories, Hercules, CA) for 5 min each and dried for 30 min at room temperature. Dried sections were incubated in PBS blocking buffer containing 0.3% Triton X-100 and 10% goat serum (Dako, Glostrup, Denmark) for 30 min and incubated overnight at 4 °C with primary antibody diluted with Can Get Signal Solution B (NKB-601, TOYOBO, Osaka, Japan) containing 10% goat serum. Dilution of the primary antibodies was as follows: rabbit anti-integrin α5 (1:50; H-104, Santa Cruz, Dallas, TX), rabbit anti-integrin αv (1:50; Q-20-R, Santa Cruz), anti-isolectin B4 (1:25; Vector Laboratories, Burlingame, CA), rabbit anti-vitronectin (1:50; Santa Cruz), rabbit antilaminin (1:50; Santa Cruz), and mouse anti-fibronectin (1:50; Santa Cruz). After washing with TBS for 5 min three times, the sections were incubated for 1 h with Alexa Fluor 546 goat anti-rabbit immunoglobulin G (IgG; Life Technologies, Carlsbad, CA) or Alexa Fluor 488 goat anti-rabbit IgG (Life Technologies) diluted to 1:250 with Can Get Signal Solution B containing 10% goat serum. Sections were washed three times with TBS containing 0.3% Triton-X 100 and sealed with Fluoromount (Diagnostic BioSystems, Pleasanton, CA). As a negative control, normal rabbit IgG diluted to 1:3,750 (Dako) was used in place of the primary antibody. Cellstain (DOJINDO, Kumamoto, Japan) diluted to 1:3,000 was used for nuclear staining.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell adhesion assay:</head><p>To confirm the selectivity and specificity of the association between integrins and ECM ligands, a cell adhesion assay was performed using primary human retinal endothelial cells (HRECs; Cell Systems, Kirkland, WA). Briefly, 75 μl vitronectin (5 μg/ml; BD, Franklin Lakes, NJ) or fibronectin (10 μg/ml, Sigma-Aldrich; concentrations showing best adhesion to HRECs) was incubated for 1 h at 37 °C in 96-well microtiter plates. After excess ECM was removed from the wells, the uncoated area in the wells was blocked with 1% BSA. HRECs suspended at 10 5 cells per ml in CSC medium (Cell Systems) containing 0.1% BSA were incubated for 30 min with antibodies for α5β1 (clone JBS5, EMD Millipore, Billerica, MA) or αvβ3 (LM609, Millipore). Ten-microliter cell suspensions were inoculated into the ECM-coated wells. After incubation for 10 min at 37 °C, the cells were fixed with 10% neutral formalin (Nacalai tesque) and stained with 0.1% crystal violet solution (Sigma-Aldrich). The statistical test and variance is stated in figure legend. The stained areas were quantified with Image-Pro (Media Cybernetics, Rockville, MD).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>Neovascularization after laser treatment: Immunohistochemistry with FITC-labeled isolectin as a marker for laserinduced neovascularization in the RPE-choroid showed blood vessels in normal, non-laser treated rats <ref type="figure" target="#fig_1">(Figure 1, Normal)</ref>, but only a few macrophages and microglial and endothelial </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Colocalization of integrin α5 and αv subunits with tubule formation:</head><p>Fluorescence microscopy with red fluorescent labeling for the α5 subunit of integrin showed weak reactivity near blood vessels throughout the RPE-choroid of normal rats <ref type="figure" target="#fig_2">(Figure 2, red arrows)</ref>. On day 1 after laser treatment, binding of the antibody for integrin α5 slightly increased; and on day 3, integrin α5 markedly increased between the subretinal and suprachoroidal spaces with ruptured Bruch's membranes (row 1, yellow arrows). Integrin α5 remained visible for 14 days. Macrophages and microglial and endothelial cells also accumulated around the laser spots on day 3 (row 2, white arrow), and angiogenic tubules (green arrows) were observed on days 7 and 14. Integrin α5 colocalized with macrophages and microglial and endothelial cells (row 3, blue arrows) on day 3 and endothelial cells on days 7 and 14. Another subunit of integrin, αv, was also observed in normal blood vessels and the RPE <ref type="figure" target="#fig_3">(Figure 3, red and orange arrows)</ref>. The appearance and accumulation of integrin αv after laser treatment ( <ref type="figure" target="#fig_3">Figure  3</ref>) were similar to those described for integrin α5. Negative controls using IgG in place of primary antibodies did not show significant binding (data not shown). Blue nuclear staining (row 4, <ref type="figure" target="#fig_2">Figure 2</ref> and <ref type="figure" target="#fig_3">Figure 3</ref>) showed overall retinal disruption on day 1 followed by progressive healing over 14 days, suggesting increased α5 and αv integrin subunitpositive cells during retinal neovascularization.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Extracellular matrix components precede accumulation of integrin-positive cells:</head><p>We found that FN and VN weakly localized around blood vessel in normal rats <ref type="figure" target="#fig_4">(Figure 4</ref>, red arrows) but markedly increased between the subretinal space and sclera with ruptured Bruch's membranes on day 1 after laser treatment <ref type="figure" target="#fig_4">(Figure 4</ref>, orange arrows). FN and VN antibody binding on day 3 was somewhat decreased but remained (yellow and blue arrows). On day 7 after laser injury, FN further decreased, but closely localized with tube-like structures <ref type="figure" target="#fig_4">(Figure 4, green arrows)</ref>. In contrast, VN almost disappeared. Day 14 was similar in appearance to day 7. Binding of antibody for laminin, another extracellular matrix protein that binds to integrin <ref type="bibr" target="#b6">[6]</ref>, did not change after laser treatment (data not shown). These data suggested that specific binding ligands, such as FN and VN, may precede and possibly   influence the accumulation of integrin α5-and αv-positive cells during retinal neovascularization.</p><p>Fibronectin and vitronectin matrix proteins bind to specific integrin subunits: An in vitro cell adherence-inhibition assay using HRECs showed that the antibody for integrin α5β1 subunit significantly (p&lt;0.01) inhibits adhesion of HRECs onto FN-coated plates ( <ref type="figure" target="#fig_5">Figure 5A</ref>). An integrin αvβ3 antibody had no effect. Conversely, the integrin αvβ3 antibody significantly inhibited adhesion of cells onto VN-coated plates, while the integrin α5β1 antibody had no effect ( <ref type="figure" target="#fig_5">Figure  5B</ref>). These data indicated that integrin α5 and αv bind specifically to FN and VN, respectively.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>The major finding of the present studies was the sequence of molecular events that occur during the onset and development of neovascularization in the laser-induced CNV model in rats ( <ref type="table" target="#tab_0">Table 1</ref>). The first major event observed 1 day after laser treatment was the accumulation of FN and VN between the subretinal space and sclera around the injured areas ( <ref type="figure" target="#fig_4">Figure  4</ref>). mRNA specific for FN is transiently increased by the terminal complement proteins C5b-8 and C5b-9 in glomerular mesangial cells <ref type="bibr" target="#b20">[20]</ref>. VN also increases in complementstimulated human RPE cells <ref type="bibr" target="#b21">[21]</ref>. The end product of complement activation, membrane attack complex (MAC), increases as early as 1 h after laser treatment <ref type="bibr" target="#b22">[22]</ref>. Thus, complement activation could be a mechanism for the early expression of FN and VN in our laser model. On day 3, binding of antibodies for integrins α5 and αv and for FITC-labeled isolectin (for macrophages and microglial, perivascular, and endothelial cells) increased markedly (Table 1, <ref type="figure" target="#fig_1">Figure 1, Figure 2</ref>, <ref type="figure" target="#fig_3">Figure 3</ref>, and <ref type="figure" target="#fig_4">Figure 4</ref>). Increased chemokine, (C-C motif) ligand 2 (CCL2), causes migration and accumulation of microglia and macrophages for uptake of cell debris <ref type="bibr" target="#b22">[22,</ref><ref type="bibr" target="#b23">23]</ref>. mRNA for CCL2 peaks at 12 h within laser-injury spots <ref type="bibr" target="#b22">[22]</ref>. In addition, mRNA for vascular endothelial growth factor (VEGF) increases 2 days after laser treatment <ref type="bibr" target="#b22">[22]</ref>, and VEGF is secreted from macrophages and microglial and RPE cells <ref type="bibr" target="#b24">[24]</ref>. Specific adherence of retinal endothelial cells, where integrins α5 and αv were expressed (confirmed with western blotting, data not shown), to FN and VN through integrin α5 and αv was also observed ( <ref type="figure" target="#fig_5">Figure  5</ref>). These data suggest that under the influence of cytokines, such as CCL2 and VEGF, integrin α5-and αv-positive macrophages and microglial and endothelial cells migrated between the subretinal and suprachoroidal spaces with ruptured Bruch's membranes. This is also where FN and VN, the specific ligands for integrins α5 and αv, accumulated. These data suggest that the increased FN and VN in laser injury may be important for the accumulation of integrin α5-and αv-positive cells. This was followed by uptake of cell debris by the macrophages and microglia and neovascularization by the endothelial cells.</p><p>On day 7, FN was retained, tube-like structures formed, and VN disappeared ( <ref type="table" target="#tab_0">Table 1</ref>). These data suggest that VN was important for the onset of neovascularization, while FN was needed for onset and further vessel development during neovascularization. Interestingly, laminin, another extracellular matrix protein found in the RPE basement membrane <ref type="bibr" target="#b25">[25]</ref>, did not increase after laser injury. These specific changes in ECM localization suggest that the association between integrin subunits and their specific ligands may be important for VEGF-induced proliferation and differentiation of endothelial progenitor cells for subsequent CNV.</p><p>Antagonists targeting single integrin subunits inhibit CNV <ref type="bibr" target="#b17">[17,</ref><ref type="bibr" target="#b18">18,</ref><ref type="bibr" target="#b26">26,</ref><ref type="bibr" target="#b27">27]</ref>. However, our current data suggested that αv and α5 integrins are important for neovascularization. Blocking of multiple integrins thus may be useful for the therapy for AMD. Only limited data are available concerning the efficacy of using antagonists to block multiple integrin subunits <ref type="bibr" target="#b28">[28]</ref>. Antagonism of multiple integrin subunits may also cause stronger side effects; further experiments testing multiple integrin antagonists are needed. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>METHODSAnimals:</head><label></label><figDesc>Twenty adult male Brown Norway rats (8-9 weeksold) were obtained from Charles River Laboratories (Yokohama, Japan) and maintained under a 12 h:12 h light-dark cycle. Senju follows the international IACUC animal research laws, policies and guidelines, and all experimental animals were handled in accordance with the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research and the NIH Guiding Principles in the Care and Use of Animals (DHEW Publication, NIH 80-23).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc>Representative flatmount images of macrophages and microglial and endothelial cells labeled with green fluorescent antibody for isolectin in normal and laser-treated rat RPE-choroid preparations. The red arrow indicates macrophages and microglial and endothelial cells; the yellow arrows indicate new tubular structures. Scale bar = 200 μm.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc>Fluorescence microscopy with red fluorescent antibody for integrin α5 in normal and laser-treated rat RPE-choroid. The red arrows show integrin α5 expression near normal blood vessels. The yellow arrows show positive red antibody binding for integrin α5 between the subretinal and suprachoroidal spaces with ruptured Bruch's membranes after laser treatment. The white arrow indicates isolectin binding in green macrophages and microglial and endothelial cells and near new tubular structures (green arrows). The blue arrows show colocalization of red integrin α5 with green macrophages and microglial and endothelial cells. Blue 4',6-diamidino-2-phenylindole (DAPI) nuclear stain highlights the disruption and wound healing in the inner and outer nuclear layers. Scale bar = 100 μm. cells stained 1 day after laser injury (day 1). Staining on day 3 indicated early accumulation of mainly macrophages and microglial cells with some endothelial cells (red arrow). On days 7 and 14, macrophages and microglial cells decreased, and tubular structures were observed (Figure 1, yellow arrows), indicating active retinal neovascularization in this rat model.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc>Fluorescence microscopy with red fluorescent antibody for integrin αv in rat RPE-choroid. Non-treated retinas show positive antibody binding for integrin αv around the normal vessels (red arrows) and in the RPE (orange arrows). The yellow arrows show positive red antibody binding for integrin αv between the subretinal and suprachoroidal spaces after laser treatment. The white arrow indicates isolectin binding in green macrophages and microglial and endothelial cells and near the new tubular structures (green arrows). The blue arrows show colocalization of red integrin αv with green macrophages and microglial and endothelial cells. Scale bar = 100 μm.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .</head><label>4</label><figDesc>Fluorescence microscopy in normal and laser-treated rat RPE-choroid, triple labeled red for fibronectin (FN, row 2) and vitronectin (VN; row 4), green for isolectin, and blue for nuclear staining. The red arrows indicate normal blood vessels. The orange arrows indicate the antibody binding for FN and VN between the subretinal space and sclera after laser treatment. The yellow and blue arrows indicate the moderate decrease in FN and disappearance in VN, respectively; the green arrows show FN localization around forming tubules. Scale bar = 100 μm.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 5 .</head><label>5</label><figDesc>Cell adhesion assay of primary human retinal endothelial cells. Adherence of human retinal endothelial cells to (A) fibronectin (FN) and (B) vitronectin (VN)coated plates were conducted in the absence (PBS) and presence of antibodies to specific integrin subunit α5β1 and αvβ3. Data are means ± standard deviation (SD; n = 3). *p&lt;0.01 relative to PBS (Dunnett's test).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Summary of changeS in inTegrinS and Their ligand ecmS during neovaScularizaTion.</head><label>1</label><figDesc></figDesc><table><row><cell>Post laser treatment, days</cell><cell>1</cell><cell cols="2">Staining intensity* 3 7</cell><cell>14</cell></row><row><cell>Fibronectin</cell><cell>+++</cell><cell>++</cell><cell>+</cell><cell>+</cell></row><row><cell>Vitronectin</cell><cell>+++</cell><cell>++</cell><cell>-/+</cell><cell>-/+</cell></row><row><cell>α5 Integrin</cell><cell>-/+</cell><cell>+++</cell><cell>++</cell><cell>+</cell></row><row><cell>αv Integrin</cell><cell>-/+</cell><cell>+++</cell><cell>++</cell><cell>+</cell></row><row><cell>Neovascularization</cell><cell>-</cell><cell>-/+</cell><cell>+</cell><cell>+</cell></row></table><note>* (-)=none, (-/+)=minimal, (+)=mild, (++)=moderate, (+++)=strong.</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© 2014 Molecular Vision</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p>Authors' Disclosure Statement: These studies were completely funded by Senju Pharmaceutical Co., Ltd. Dr. Shearer is a paid consultant for Senju Pharmaceutical Co., Ltd., a company that may have a commercial interest in the results of this research and technology. Drs. Azuma and Hirata are employees of Senju Pharmaceutical Co., Ltd. These potential conflicts of interest were reviewed, and management plans approved by the OHSU Conflict of Interest in Research Committee were implemented.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A review of drug options in age-related macular degeneration therapy and potential new agents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><surname>Yeoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanne</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robyn</forename><forename type="middle">H</forename><surname>Guymer</surname></persName>
		</author>
		<idno type="DOI">10.1517/14656566.7.17.2355</idno>
		<idno type="PMID">17109611</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Opinion on Pharmacotherapy</title>
		<title level="j" type="abbrev">Expert Opinion on Pharmacotherapy</title>
		<idno type="ISSN">1465-6566</idno>
		<idno type="ISSNe">1744-7666</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="2355" to="2368" />
			<date type="published" when="2006-11-17" />
			<publisher>Informa Healthcare</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Age-related macular degeneration (AMD): pathogenesis and therapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Z</forename><surname>Nowak</surname></persName>
		</author>
		<idno type="PMID">16845209</idno>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Rep</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="353" to="63" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Friedlander</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">L</forename><surname>Theesfeld</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Sugita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fruttiger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Cheresh</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.93.18.9764</idno>
		<idno type="PMID">8790405</idno>
		<idno type="PMCID">PMC38503</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/93/18/9764.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="9764" to="9769" />
			<date type="published" when="1996-09-03" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<idno type="PMID">8790405</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="9764" to="9773" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Expression of integrins on human choroidal neovascular membranes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Maberley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arif</forename><surname>Samad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allison</forename><surname>Ning</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanne</forename><forename type="middle">A</forename><surname>Matsubara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Baciu</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12177-009-9015-9</idno>
		<idno type="PMID">20072642</idno>
		<idno type="PMCID">PMC2802503</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.1007%2Fs12177-009-9015-9.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Ocular Biology, Diseases, and Informatics</title>
		<title level="j" type="abbrev">j ocul biol dis inform</title>
		<idno type="ISSNe">1936-8445</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12" to="19" />
			<date type="published" when="2009-02-24" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The integrins</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshikazu</forename><surname>Takada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaojing</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><surname>Simon</surname></persName>
		</author>
		<idno type="DOI">10.1186/gb-2007-8-5-215</idno>
		<idno type="PMID">17543136</idno>
		<idno type="PMCID">PMC1929136</idno>
		<ptr type="open-access" target="https://genomebiology.biomedcentral.com/track/pdf/10.1186/gb-2007-8-5-215" />
	</analytic>
	<monogr>
		<title level="j">Genome Biology</title>
		<title level="j" type="abbrev">Genome Biol</title>
		<idno type="ISSN">1465-6906</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">215</biblScope>
			<date type="published" when="2007" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Integrins</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Malgorzata</forename><surname>Barczyk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sergio</forename><surname>Carracedo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donald</forename><surname>Gullberg</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00441-009-0834-6</idno>
		<idno type="PMID">19693543</idno>
		<idno type="PMCID">PMC2784866</idno>
		<idno type="ark">ark:/67375/VQC-LVFHMLGT-S</idno>
		<idno type="istexId">6E39E744C5EE9A64DDF7B21EA30E6DEAEB5605FE</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.1007%2Fs00441-009-0834-6.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cell and Tissue Research</title>
		<title level="j" type="abbrev">Cell Tissue Res</title>
		<idno type="ISSN">0302-766X</idno>
		<idno type="ISSNe">1432-0878</idno>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="269" to="280" />
			<date type="published" when="2009-08-20" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Integrin Targeted Therapeutics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Melissa</forename><surname>Millard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Srinivas</forename><surname>Odde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nouri</forename><surname>Neamati</surname></persName>
		</author>
		<idno type="DOI">10.7150/thno/v01p0154</idno>
		<idno type="PMID">21547158</idno>
		<idno type="PMCID">PMC3086618</idno>
		<ptr type="open-access" target="http://www.thno.org/v01p0154.pdf" />
	</analytic>
	<monogr>
		<title level="j">Theranostics</title>
		<title level="j" type="abbrev">Theranostics</title>
		<idno type="ISSN">1838-7640</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="154" to="188" />
			<date type="published" when="2011" />
			<publisher>Ivyspring International Publisher</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ffrench-Constant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">O</forename><surname>Hynes</surname></persName>
		</author>
		<idno type="PMID">2591321</idno>
	</analytic>
	<monogr>
		<title level="j">Development</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="375" to="88" />
			<date type="published" when="1989" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young-Chul</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raymond</forename><surname>Tsou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><forename type="middle">S</forename><surname>Gibran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">Frank</forename><surname>Isik</surname></persName>
		</author>
		<idno type="DOI">10.1067/msy.2000.105858</idno>
		<idno type="PMID">10840366</idno>
		<idno type="PII">S0039-6060(00)82584-2</idno>
		<idno type="ark">ark:/67375/6H6-WV3XB018-6</idno>
		<idno type="istexId">6EDE234239027B6012398B3B6FEBF2153DBEFB1D</idno>
	</analytic>
	<monogr>
		<title level="j">Surgery</title>
		<title level="j" type="abbrev">Surgery</title>
		<idno type="ISSN">0039-6060</idno>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="696" to="704" />
			<date type="published" when="2000-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">CELL-MATRIX ADHESION IN VASCULAR DEVELOPMENT</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">O</forename><surname>Hynes</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1538-7836.2007.tb00826.x</idno>
		<idno type="PMID">17635706</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Thrombosis and Haemostasis</title>
		<title level="j" type="abbrev">Journal of Thrombosis and Haemostasis</title>
		<idno type="ISSN">1538-7933</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">PLEN-M-003-PLEN-M-003</biblScope>
			<date type="published" when="2007-07" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Requirement of vascular integrin alpha v beta 3 for angiogenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pccr</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Cheresh</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.7512751</idno>
		<idno type="PMID">7512751</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">264</biblScope>
			<biblScope unit="issue">5158</biblScope>
			<biblScope unit="page" from="569" to="571" />
			<date type="published" when="1994-04-22" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Central Roles of alpha5beta1 Integrin and Fibronectin in Vascular Development in Mouse Embryos and Embryoid Bodies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Segk</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Hodivala-Dilke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">L</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Stark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">O</forename><surname>Hynes</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.atv.0000016045.93313.f2</idno>
		<idno type="PMID">12067900</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.0000016045.93313.F2" />
	</analytic>
	<monogr>
		<title level="j">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<idno type="ISSN">1079-5642</idno>
		<idno type="ISSNe">1524-4636</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="927" to="933" />
			<date type="published" when="2002-03-21" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Vascular Integrins: Therapeutic and Imaging Targets of Tumor Angiogenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Curzio</forename><surname>Rüegg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gian</forename><forename type="middle">Carlo</forename><surname>Alghisi</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-540-78281-0_6</idno>
		<idno type="PMID">20033379</idno>
	</analytic>
	<monogr>
		<title level="m">Angiogenesis Inhibition</title>
		<imprint>
			<publisher>Springer Berlin Heidelberg</publisher>
			<date type="published" when="2009-10-07" />
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="83" to="101" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Alpha-v Integrins as Therapeutic Targets in Oncology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">A</forename><surname>Nemeth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marian</forename><forename type="middle">T</forename><surname>Nakada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Trikha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhihui</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">S</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gordon</forename><forename type="middle">C</forename><surname>Jayson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Corringham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Uma</forename><surname>Prabhakar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hugh</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Beckman</surname></persName>
		</author>
		<idno type="DOI">10.1080/07357900701522638</idno>
		<idno type="PMID">18027153</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Investigation</title>
		<title level="j" type="abbrev">Cancer Investigation</title>
		<idno type="ISSN">0735-7907</idno>
		<idno type="ISSNe">1532-4192</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="632" to="646" />
			<date type="published" when="2007-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Investigation of Laser-Induced Choroidal Neovascularization in the Rat</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irina</forename><surname>Semkova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Swaantje</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerhard</forename><surname>Welsandt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hanna</forename><surname>Janicki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jens</forename><surname>Jordan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ulrich</forename><surname>Schraermeyer</surname></persName>
		</author>
		<idno type="DOI">10.1167/iovs.02-0732</idno>
		<idno type="PMID">14638737</idno>
		<ptr type="open-access" target="https://iovs.arvojournals.org/data/journals/iovs/932917/z7g01203005349.pdf" />
	</analytic>
	<monogr>
		<title level="j">Investigative Opthalmology &amp; Visual Science</title>
		<title level="j" type="abbrev">Invest. Ophthalmol. Vis. Sci.</title>
		<idno type="ISSN">1552-5783</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">5349</biblScope>
			<date type="published" when="2003-12-01" />
			<publisher>Association for Research in Vision and Ophthalmology (ARVO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Pathogenesis of laser-induced choroidal subretinal neovascularization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ishibashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Ryan</surname></persName>
		</author>
		<idno type="PMID">1692312</idno>
	</analytic>
	<monogr>
		<title level="j">Invest Ophthalmol Vis Sci</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="899" to="908" />
			<date type="published" when="1990" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an 5beta1 Integrin Antagonist</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Umeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kachi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Zahn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Vossmeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Stragies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Campochiaro</surname></persName>
		</author>
		<idno type="DOI">10.1124/mol.105.020941</idno>
		<idno type="PMID">16527907</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/0c94/10525df5a7628ee81f68855c8e8698874735.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular Pharmacology</title>
		<title level="j" type="abbrev">Molecular Pharmacology</title>
		<idno type="ISSN">0026-895X</idno>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1820" to="1828" />
			<date type="published" when="2006-03-01" />
			<publisher>American Society for Pharmacology &amp; Experimental Therapeutics (ASPET)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Anti-angiogenic effects of non-peptide integrin αvβ3 specific antagonist on laser-induced choroidal neovascularization in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeru</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takayuki</forename><surname>Nagai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akira</forename><surname>Negi</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00417-008-1010-5</idno>
		<idno type="PMID">19048271</idno>
		<idno type="ark">ark:/67375/VQC-TQ274745-1</idno>
		<idno type="istexId">9ABC57BD59E7857DD90A6C4228D96C7448893B86</idno>
	</analytic>
	<monogr>
		<title level="j">Graefe&apos;s Archive for Clinical and Experimental Ophthalmology</title>
		<title level="j" type="abbrev">Graefes Arch Clin Exp Ophthalmol</title>
		<idno type="ISSN">0721-832X</idno>
		<idno type="ISSNe">1435-702X</idno>
		<imprint>
			<biblScope unit="volume">247</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="515" to="522" />
			<date type="published" when="2008-12-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Chronotopographical distribution patterns of cell death and of lectin-positive macrophages/microglial cells during the visual system ontogeny of the small-spotted catsharkScyliorhinus canicula</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Bejarano-Escobar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Manuel</forename><surname>Blasco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><forename type="middle">Carmen</forename><surname>Durán</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gervasio</forename><surname>Martín-Partido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Javier</forename><surname>Francisco-Morcillo</surname></persName>
		</author>
		<idno type="DOI">10.1111/joa.12071</idno>
		<idno type="PMID">23758763</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Anatomy</title>
		<title level="j" type="abbrev">J. Anat.</title>
		<idno type="ISSN">0021-8782</idno>
		<imprint>
			<biblScope unit="volume">223</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="171" to="184" />
			<date type="published" when="2013-06-13" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Braunger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Rother</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Hansch</surname></persName>
		</author>
		<idno type="PMID">8081997</idno>
	</analytic>
	<monogr>
		<title level="j">Exp Nephrol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="51" to="57" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Increased Vitronectin Production by Complement-Stimulated Human Retinal Pigment Epithelial Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susanne</forename><surname>Wasmuth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katharina</forename><surname>Lueck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hanna</forename><surname>Baehler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Albrecht</forename><surname>Lommatzsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Pauleikhoff</surname></persName>
		</author>
		<idno type="DOI">10.1167/iovs.08-3326</idno>
		<idno type="PMID">19407013</idno>
		<ptr type="open-access" target="https://iovs.arvojournals.org/data/journals/iovs/933244/z7g01109005304.pdf" />
	</analytic>
	<monogr>
		<title level="j">Investigative Opthalmology &amp; Visual Science</title>
		<title level="j" type="abbrev">Invest. Ophthalmol. Vis. Sci.</title>
		<idno type="ISSN">1552-5783</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">5304</biblScope>
			<date type="published" when="2009-11-01" />
			<publisher>Association for Research in Vision and Ophthalmology (ARVO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juan</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Purushottam</forename><surname>Jha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valeriy</forename><forename type="middle">V</forename><surname>Lyzogubov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruslana</forename><forename type="middle">G</forename><surname>Tytarenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nalini</forename><forename type="middle">S</forename><surname>Bora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Puran</forename><forename type="middle">S</forename><surname>Bora</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m111.226266</idno>
		<idno type="PMID">21515678</idno>
		<idno type="PMCID">PMC3121483</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/286/23/20991.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="20991" to="21001" />
			<date type="published" when="2011-04-22" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Myeloid Cells Expressing VEGF and Arginase-1 Following Uptake of Damaged Retinal Pigment Epithelium Suggests Potential Mechanism That Drives the Onset of Choroidal Angiogenesis in Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Copland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shintaro</forename><surname>Horie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei-Kang</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mei</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yunhe</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Paul Morgan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heping</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lindsay</forename><forename type="middle">B</forename><surname>Nicholson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">D</forename><surname>Dick</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0072935</idno>
		<idno type="PMID">23977372</idno>
		<idno type="PMCID">PMC3745388</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072935&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e72935</biblScope>
			<date type="published" when="2013-08-16" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Role of PI3K/Akt and MEK/ERK in Mediating Hypoxia-Induced Expression of HIF-1α and VEGF in Laser-Induced Rat Choroidal Neovascularization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiu-Mei</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu-Sheng</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yan</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Feng</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jie</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Da-Ke</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Wiedemann</surname></persName>
		</author>
		<idno type="DOI">10.1167/iovs.08-2591</idno>
		<idno type="PMID">19098317</idno>
		<ptr type="open-access" target="https://iovs.arvojournals.org/data/journals/iovs/932957/z7g00409001873.pdf" />
	</analytic>
	<monogr>
		<title level="j">Investigative Opthalmology &amp; Visual Science</title>
		<title level="j" type="abbrev">Invest. Ophthalmol. Vis. Sci.</title>
		<idno type="ISSN">1552-5783</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">1873</biblScope>
			<date type="published" when="2009-04-01" />
			<publisher>Association for Research in Vision and Ophthalmology (ARVO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The dynamic nature of Bruch&apos;s membrane</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Booij</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Baas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Beisekeeva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">G M F</forename><surname>Gorgels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A B</forename><surname>Bergen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.preteyeres.2009.08.003</idno>
		<idno type="PMID">19747980</idno>
	</analytic>
	<monogr>
		<title level="j">Progress in Retinal and Eye Research</title>
		<title level="j" type="abbrev">Progress in Retinal and Eye Research</title>
		<idno type="ISSN">1350-9462</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2010-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Angiogenesis Inhibition and Choroidal Neovascularization Suppression by Sustained Delivery of an Integrin Antagonist, EMD478761</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yingli</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Lourdes</forename><surname>Ponce</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michelle</forename><surname>Thill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nam</forename><forename type="middle">Sun</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karl</forename><forename type="middle">G</forename><surname>Csaky</surname></persName>
		</author>
		<idno type="DOI">10.1167/iovs.07-0469</idno>
		<idno type="PMID">17962472</idno>
		<ptr type="open-access" target="https://iovs.arvojournals.org/data/journals/iovs/933442/z7g01107005184.pdf" />
	</analytic>
	<monogr>
		<title level="j">Investigative Opthalmology &amp; Visual Science</title>
		<title level="j" type="abbrev">Invest. Ophthalmol. Vis. Sci.</title>
		<idno type="ISSN">1552-5783</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">5184</biblScope>
			<date type="published" when="2007-11-01" />
			<publisher>Association for Research in Vision and Ophthalmology (ARVO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Inhibition of experimental choroidal neovascularization in rats by an av-integrin antagonist</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsutomu</forename><surname>Yasukawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wolfram</forename><surname>Eichler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ulrike</forename><surname>Friedrichs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu-Sheng</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Wiedemann</surname></persName>
		</author>
		<idno type="DOI">10.1076/ceyr.28.5.359.28678</idno>
		<idno type="PMID">15287373</idno>
	</analytic>
	<monogr>
		<title level="j">Current Eye Research</title>
		<title level="j" type="abbrev">Current Eye Research</title>
		<idno type="ISSN">0271-3683</idno>
		<idno type="ISSNe">1460-2202</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="359" to="366" />
			<date type="published" when="2004-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Nanoparticle–integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyuncheol</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karl</forename><forename type="middle">G</forename><surname>Csaky</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jconrel.2009.10.031</idno>
		<idno type="PMID">19895863</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Controlled Release</title>
		<title level="j" type="abbrev">Journal of Controlled Release</title>
		<idno type="ISSN">0168-3659</idno>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="286" to="293" />
			<date type="published" when="2010-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">This reflects all typographical corrections and errata to the article through that date. Details of any changes may be</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">R</forename><surname>China</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014-06" />
		</imprint>
		<respStmt>
			<orgName>Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University</orgName>
		</respStmt>
	</monogr>
	<note>The print version of this article was created on 19. found in the online version of the article</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
